Wir verwenden standardmäßig essenzielle Cookies (Anmeldung, deine gespeicherten Ziele/Stacks). Mit deiner Erlaubnis aktivieren wir außerdem datenschutzfreundliche Analytik (Vercel Web Analytics, anonyme Ladezeit-Metriken) und Fehler-Replay-Diagnostik (Sentry — DOM-Snapshots nur, wenn ein Fehler auftritt), damit wir Bugs schneller beheben können. Mehr über Cookies erfahren
Arl3.0
Argireline – Forschung
Überwiegend Mechanismus / Beobachtung
8 begutachtete Studien
Was die Evidenz sagt
Überwiegend Mechanismus / Beobachtung
Die meisten Studien zu Argireline sind mechanistisch oder beobachtend statt RCTs, die einen klinischen Effekt messen — betrachte die Ergebnisse als vorläufig.
Die meiste Evidenz stammt aus gemischt-qualitativen randomisierten Studien, veröffentlicht 2002–2025.
Basierend auf 8 Studien · 3 RCTs
Konfidenz
Mittlere Konfidenz
Nach Outcome
Skin healthGeringfügige Reduktion des Erscheinungsbilds von Mimikfalten (kosmetisch, kein gesundheitlicher Effekt) · 4-8 Wochen
Überwiegend Mechanismus / Beobachtung5 Studien
Safety profile
Zu wenige bewertete Studien1 Studie
Stetige Forschung
2 Studien in den letzten 5 Jahren
200220132025
1Systematische Übersicht2025
This review emphasizes the need for further research on formulation science and delivery systems, which are essential for optimizing the effectiveness of peptide-based cosmeceuticals and validating their use as non-invasive alternatives to injectable treatments.
Zdrada-Nowak J, Surgiel-Gemza A, Szatkowska M. · International journal of molecular sciences (2025)
However, the precise biological mechanisms underlying these effects-particularly the peptide's ability to inhibit muscle contraction when applied topically-remain incompletely understood.
In some studies, AH-8 has also shown beneficial effects in scar remodeling and sebum regulation.
Despite promising cosmetic outcomes, AH-8's low skin penetration limits its bioavailability and therapeutic potential.
Conclusion Topical cosmeceuticals like botanicals, peptides and hydroquinone can effectively treat photodamaged skin.
Chan LKW, Lee KWA, Lee CH, Lam KWP, Lee KFV, Wu R, Wan J, Shivananjappa S, Sky WTH, Choi H, Yi KH. · Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) (2024)
Results Most of the evidence behind cosmeceuticals is of high-quality ranging from Level I to Level II.
In particular, the evidence base behind peptides is the strongest with most studies achieving Level Ib status in the evidence hierarchy.
Conclusion Topical cosmeceuticals like botanicals, peptides and hydroquinone can effectively treat photodamaged skin.
In the objective evaluation, the parameters of roughness were all decreased in the argireline group (p < 0.01), while no decrease was obvious in the placebo group (p > 0.05).
Wang Y, Wang M, Xiao S, Pan P, Li P, Huo J. · Am J Clin Dermatol (2013)
Randomized, placebo-controlled topical trial: 60 subjects (3:1 Argireline:placebo) applied product to peri-orbital wrinkles twice daily for 4 weeks
Objective silicone-replica wrinkle analysis showed all roughness parameters decreased significantly in the Argireline group (p < 0.01) and not in placebo
Subjective total anti-wrinkle efficacy was 48.9% with Argireline vs 0% with placebo
Double-blind, placebo-controlled, randomized trial of daily topical application of AH8 in 24 patients with BSP... There were no significant adverse events.
Lungu C, Considine E, Zahir S, Ponsati B, Arrastia S, Hallett M. · Eur J Neurol (2013)
NIH double-blind, placebo-controlled, randomized pilot of topical acetyl hexapeptide-8 (a competitive SNAP-25 inhibitor) in 24 blepharospasm patients
No significant adverse events — supports topical safety
Only a non-significant trend toward longer time to return to baseline after botulinum-toxin injection in the active group (3.7 vs 3.0 months)
skin topography analysis of an oil/water (O/W) emulsion containing 10% of the hexapeptide on healthy women volunteers reduced wrinkle depth up to 30% upon 30 days treatment.
Blanes-Mira C, Clemente J, Jodas G, Gil A, Fernández-Ballester G, Ponsati B, Gutierrez L, Pérez-Payá E, Ferrer-Montiel A. · Int J Cosmet Sci (2002)
Foundational design paper: the hexapeptide Ac-EEMQRR-NH2 ('Argireline') was rationally designed to mimic the cosmetic action of botulinum toxin non-toxically
A 10% O/W emulsion reduced wrinkle depth up to ~30% over 30 days in a small, uncontrolled cohort of healthy women — an appearance measure, not a controlled trial
Mechanistically, the peptide inhibited neurotransmitter release with potency similar to BoNT-A but much lower efficacy, by interfering with SNARE-complex formation/stability
Our results confirm the antiwrinkle activity of acetyl hexapeptide-3. A significant decrease in TEWL with acetyl hexapeptide-3 treatment is observed.
Raikou V, Varvaresou A, Panderi I, Papageorgiou E. · J Cosmet Dermatol (2017)
Prospective, randomized controlled cosmetic-science study in 24 volunteers comparing acetyl hexapeptide-3, tripeptide-10-citrulline, their combination, and neither, over 60 days
the significant cytotoxicity of argireline solution was observed under 18 to 10 000 fold higher concentrations (depending on cells that were examined) in comparison to doxorubicin.
Grosicki M, Latacz G, Szopa A, Cukier A, Kieć-Kononowicz K. · Acta Biochim Pol (2014)
Independent in-vitro cytotoxicity study across HEK-293, IMR-32 neuroblastoma, and human primary skin fibroblasts
Anti-proliferative effects were dose-dependent but appeared only at 18- to 10,000-fold higher concentrations than the reference cytotoxin doxorubicin
Supports a wide topical safety margin for cosmetic-use concentrations
8Übersicht2007
This article reviews the physiological basis and mechanism of action of the active cosmetic ingredient acetyl hexapeptide-8 (Argireline).